Loading clinical trials...
Loading clinical trials...
Alzheimer's disease (AD) is a neurodegenerative disorder affecting almost 6% of the world's population over the age of 65. This disease, in its most typical sporadic form, is characterized by an episo...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
University Hospital, Tours
NCT05592678 · Alzheimer's Disease (AD), Dementia, and more
NCT07422857 · Subjects With Mild Cognitive Impairment (MCI) of AD, Alzheimer's Disease (AD) Dementia
NCT06891716 · Frontotemporal Dementia (FTD), Amyotrophic Lateral Sclerosis (ALS), and more
NCT07529015 · Alzheimer's Disease (AD), Mild Cognitive Impairment (MCI) Amnestic, and more
NCT07458620 · Alzheimer's Disease (AD)
University Hospital of Tours
Tours
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions